The effects of cost-sharing in health care: What do we know from empirical evidence?

Economia Politica

Volumn 27, Issue 2, 2010, Pages 351-374

  Carrieri, Vincenzo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957821305     PISSN: 11202890     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. Adams A.S. - Soumerai S.B. - Ross-Degnan D. (2001), Use of Antihypertensive Drugs by Medicare Enrollees: Does Type of Drug Coverage Matter?, Health Affairs, vol.20, no.1, pp. 276-286.
2. Almarsdottir A.B. - Morgall J.M. - Grimsson A. (2000), Cost Containment of Pharmaceutical Use in Iceland: The Impact of Liberalization and User Charges, Journal of Health Services Research and Policy, vol.5, no.2, pp. 109-113.
3. Aronson J.R. - Johnson P. - Lambert P.J. (1994), Redistributive Effect and Unequal Tax Treatment, Economic Journal, vol.104, no.423, pp. 262-270.
4. Atella V. - Deb P. (2008), Are Primary Care Physicians, Public and Private Sector Specialists Substitutes or Complements? Evidence from a Simultaneous Equations Model for Count Data, Journal of Health Economics, vol.27, no.3, pp. 770-785.
5. Balkrishnan R. - Byerly W.G.- Camacho F.T. - Shrestha A. - Anderson R.T. (2001), Effect of Prescription Benefit Changes on Medical Care Utilization in a Medicare HMO Population, American Journal of Managed Care, vol.7, pp. 1093-1100.
6. Blais L. - Couture J. - Rahme E. - LeLorier J. (2001), Impact of a Cost-sharing Drug Insurance Plan on Drug Utilization among Older People, Journal of the American Geriatric Society, vol.49, no.4, pp. 410-414.
7. Blustein J. (1995), Medicare Coverage, Supplemental Insurance, and the Use of Mammography by Older Women, New England Journal of Medicine, vol.332, no.17, pp. 1138-1143.
8. - (2000), Drug Coverage and Drug Purchases by Medicare Beneficiaries with Hypertension, Health Affairs, vol.19, pp. 219-230.
9. Cantor J. (1988), The Burden of Financing Health Care in the United States, John Hopkins School of Hygiene and Public Health, Baltimore, mimeo.
10. Christensen B. (1995), Payment and Attendance at General Practice Preventive Health Examinations, Family Medicine, vol.27, no.8, pp. 531-534.
11. - (1995a) Characteristics of Attenders and Non-attenders at Health Examinations for Ischemic Heart Disease in General Practice, Scandinavian Journal of Primary Health Care, vol.13, no.1, pp. 26-31.
12. Chernew M.E. Rosen A. - Fendrick A.M. (2007), Value-based Insurance Design, Health Affairs, vol.26, no.2, pp. 195-203.
13. Cox E. - Jernigan C. - Joel Coons S. - Draugalis J.R. (2001), Medicare Beneficiaries' Management of Capped Prescription Benefits, Medical Care, vol.39, no.3, pp. 296-301.
14. Culler S.D.- Parchman M.L.- Przybylski M. (1998), Factors Related to Potentially Preventable Hospitalizations among the Elderly, Medical Care, vol.36, no.6, pp. 804-817.
15. Doescher M.P. - Franks P. - Banthin J.S. (2000), Supplemental Insurance and Mortality in Elderly Americans: Findings from a National Cohort, Archives ofVamily Medicine, vol.9, pp. 251-257.
16. European Commission (2009), Aging Working Group Ageing Report. Economic and Budgetary Projections for the EU-27 Member States (2008-2060), European Economy, vol.2, ECOFIN.
17. Evans R.G. (1974), Supplier-induced Demand: Some Empirical Evidence and Implications, in Perlman M. (Ed.), The Economics of Health and Medical Care, New York, Macmillan.
18. Fahs M.C. (1992), Physician Response to the United Mine Workers' Cost-sharing Program: The other Side of the Coin, Health Services Research, vol.27, no.1, pp. 25-45.
19. Federman A.D. - Adams A.S. - Ross-Degnan D. - Soumerai, S.B. - Ayanian J.Z. (2001), Supplemental Insurance and Use of Effective Cardiovascular Drugs among Elderly Medicare Beneficiaries with Coronary Heart Disease, Journal of the American Medical Association, vol.286, pp. 1732-1739.
20. Fabbri D. - Monfardini C. (2009), Rationing the Public Provision of Healthcare in the Presence of Private Supplements: Evidence from the Italian NHS, Journal of Health Economics, vol.28, no.2, pp. 290-304.
21. Gardiol L. - Geoffard P. - Grandchamp C. (2005), Separating Selection and Incentive Effects in Health Insurance, PSE Working Papers, pp. 2005-2038, mimeo.
22. Gottshalk P. - Wolfe B. - Haveman, R. (1989), Health Care Financing in the US, UK, and The Netherlands, Distributional Consequences, in Chiancone A. - Messere K. (Eds.), Changes in Revenue Structures, Detroit, Wayne State University Press.
23. Green J. (1978), Physician Induced Demand for Medical Care, Journal of Human Resources, vol.13, supplement, pp. 21-34.
24. Hadley J. - Holahan J. - Scanlon W. (1979), Can Fee-for-Service Reimbursement Coexist with Demand Creation?, Inquiry, vol.16, no.3, pp. 247-258.
25. Hanau C. - Rizzi D. (1986), Econometria dei provvedimenti pubblici sull'assistenza farmaceutica: il caso dell'Emilia Romagna, Economia pubblica, vol.3, pp. 177-183.
26. Hillman A.L. - Pauly M.V. - Escarce J.J. - Ripley K. - Gaynor M. - Clouse J. - Ross R. (1998), Financial Incentives and Drug Spending in Managed Care, Health Affairs, vol.18, no.2, pp. 189-200.
27. Hitiris T. (2000), Prescription Charges in the United Kingdom: A Critical Review, Discussion Papers in Economics, no.4, University of York Press, mimeo.
28. Ho P.M. et al, (2002), Lack of an Association between Medicare Supplemental Insurance and Delay in Seeking Emergency Care for Patients with Myocardial Infarction, Annals of Emergency Medicine, vol.40, no.3, pp. 381-387.
29. Hurst J.W. (1985), Financing Health Services in the United States, Canada and Britain, NuffieldReverhulme Fellowship Report, King Edward's Hospital Fund For London, mimeo.
30. Hux J.E. - Naylor C.D. - Fielding D.A. (1997), The Ontario Drug Benefit Program Copayment: Its Impact on Access for Ontario Seniors and Charges to the Program, Toronto, Institute for Clinical Evaluative Sciences in Ontario, 1997, mimeo.
31. Johnson R.E. -Goodman M.J. - Hornbrook M.C. - Eldredge M.B. (1997), The Impact of Increasing Patient Prescription Drug Cost-Sharing on Therapeutic Classes of Drugs Received and on the Health Status of Elderly HMO Members, Health Services Research, voL 32, pp. 103-122.
32. Kakwani N.C. (1977), Measurement of Tax Progressivity: An International Comparison, Economic Journal, vol.89, no.345, pp. 71-80.
33. Kasje W.N. - Timmer J.W. - Boendermaker P.M. - Haaijer-Ruskamp F.M. (2002), Dutch GPs' Perceptions: The Influence of Out-of-Pocket Costs on Prescribing, Social Science and Medicine, vol.55, no.9, pp. 1571-1578.
34. Kennedy J. - Erb C. (2002), Prescription Noncompliance Due to Cost among Adults with Disabilities in the United States, American Journal of Public Health, vol.92, no.7, pp. 1120-1124.
35. Laidlaw D.P. et al. (1994), The Sight Test Fee: Effect on Ophthalmology Referrals and Rate of Glaucoma Detection, British Medical Journal, vol.309, pp. 634-636.
36. Lairson D.R. - Hindson P. - Hauquitz A. (1985), Equity of Health Care in Australia, Social Science and Medicine, vol.41, no.4, pp. 475-482.
37. Lang T. - Davido A. - Diakite B. - Agay E. - Viel J.F. - Flicoteaux B. (1997), Using the Hospital Emergency Department as a Regular Source of Care, European Journal of Epidemiology, vol.13, pp. 223-228.
38. Lavers R.J. (1989), Prescription Charges, the Demand for Prescriptions and Morbidity, Applied Economics, vol.21, pp. 1043-1052.
39. Leibowitz A. - Manning W.G. - Newhouse J.P. (1985), The Demand for Prescription Drugs as a Function of Cost-Sharing, Social Science and Medicine, vol.21, no.10, pp. 1063-1069.
40. Lexchin J. - Grootendorst P. (2002), The Effects of Prescription Drug User Fees on Health Services Use and Health Status: A Review of the Evidence, Toronto, University of Toronto Press.
41. Lichtenberg F. (2002), The Effects of Medicare on Health Care Utilization and Outcomes, in Garber A. (Ed.) (2002), Frontiers in Health Policy Research vol. 5, Cambridge, MA, MIT Press, pp. 27-52.
42. Lohr K.N. et al. (1986), Effect of Cost-Sharing on Use of Medically Effective and Less Effective Care, Medical Care 24 (Supplement), pp. 31-38.
43. Long S.H. (1994), Prescription Drugs and the Elderly: Issues and Options, Health Affairs, vol.13, no.2, pp. 157-174.
44. Magid D.J. - Koepsell T.D. - Every N. - Martin J.S. - Siscovick Wagner E.H - Weaver W.D. (1997), Absence of Association between Insurance Copayments and Delays in Seeking Emergency Care among Patients with Myocardial Infarction, New England Journal of Medicine, vol.336, pp. 1722-1729.
45. Manning W.G. et al. (1987), Health Insurance and the Demand for Medical Care: Evidence from a Randomized Experiment, American Economic Review, vol.77, no.3, pp. 251-277.
46. Mapelli V. (2005), Spesa farmaceutica ed invecchiamento della popolazione: le indicazioni di uno studio dell'ASL Milano 1, Politiche Sanitarie, vol.6, no.3, pp. 116-126.
47. Martin P. (1995), La contribution de deux dollars: un an et deux ans après, Portrait evolutif du programmes de medicament pour le personnes agees, Quebece, Régie de l'assurance maladie du Québec, Direction Generale de l'evaluation e du control, mimeo.
48. Matsuoka K.J. - Rice T. (2004), The Impact of Cost-Sharing on Appropriate Utilization and Health Status: A Review of Literature on Seniors, Medical Care Research Review, vol.61, pp. 415-452.
49. Nelson A.A.- Reeder C.E. - Dickson W.M. (1984), The Effect of a Medicaid Drug Copayment Program on the Utilization and Cost of Prescription Services, Medical Care, vol.22, no.8, pp. 724-736.
50. Nexoe J. - Kragstrup J. - Rønne T. (1997), Impact of Postal Invitations and User Fee on Influenza Vaccination Rates among the Elderly. A Randomized Controlled Trial in General Practice, Scandinavian Journal of Primary Health Care, vol.15, no.2, pp. 109-112. (Pubitemid 27293724)
51. O'Grady K.F. - Manning W.G. - Newhouse J.P. - Brook R.H. (1985), The Impact of Cost-Sharing on Emergency Department Use, New England Journal of Medicine, vol.313, no.8, pp. 484-490.
52. OECD (2008), Health at Glance-OECD Indicators 2007 first edition, Paris.
53. Pauly M.V. (1968), The Economics of Moral Hazard: Comment, American Economic Review, vol.58, no.3, pp. 531-537.
54. Pauly M.V. - Blavin F.E. (2008), Moral Hazard in Insurance, Value-Based Cost-Sharing and the Benefits of Blissful Ignorance, Journal of Health Economics, vol.27, no.1, pp. 1407-1417.
55. Persson A. - Guzelgun Z. (1998), Taxes, Premiums, User Charges: Financing from the Point of View of Consumers, Developments in Health Economic and Public Policy, vol.7, pp. 255-272.
56. Phelps C. - Newhouse J.P. (1972), Effect of Coinsurance: A Multivariate Analyisis, Soc. Secur. Bull., vol.35, no.6, pp. 20-28.
57. Pilote L. - Beck C. - Richard H. - Eisenberg M.J. (2002), The Effects of Cost-Sharing on Essential Drug Prescriptions, Utilization of Medical Care and Outcomes after Acute Myocardial Infarction in Elderly Patients, Canadian Medical Association Journal, vol.167, pp. 246-252.
58. Putnam et al. (2002), Chronic Disease Score as a Predictor of Hospitalization, Epidemiology, vol.13, no.3, pp. 340-346.
59. Rassell E. - Tang K. (1994), Paying for Health Care: Affordability and Equity in Proposal of Health Care Reform, Working Paper Economic Policy Institute, Washington DC, mimeo.
60. Reeder C.E. - Nelson A.A. (1985), The Differential Impact of Copayment on Drug Use in a Medicaid Population, Inquiry, vol.22, no.4, pp. 396-403.
61. Rice T. - Morrison K.R. (1994), Patient Cost-Sharing for Medical Services: A Review of the Literature and Implications for Health Care Reform, Medical Care Review, vol.51, no.3, pp. 235-287.
62. Roddy P.C. - Wallen, J. - Meyers S.M. (1986), Cost-Sharing and the Use of Health Services: The United Mine Workers of America Health Plan, Medical Care, vol.24, no.9, pp. 873-876.
63. Safran D.G. - Neuman P. - Schoen C. - Montgomery J.E. - Li W. - Wilson I.B. -Kitchman M.S. - Bowan A.E. - Rogers W.H. (2002), Prescription Drug Coverage and Seniors: How Well are States Closing the Gap?, Health Affairs, Supplement Web Exclusives, pp. W253-W268.
64. Scheffler R.M. (1984), United Mine Workers' Health Plan: An Analysis of the Cost-sharing Program, Medical Care, vol.22, no.3, pp. 247-254.
65. Schellhorn M. (2001), The Effect of Variable Health Insurance Deductibles on the Demand for Physician Visits, Health Economics, vol 10, no.5, pp. 441-456.
66. Scitovsky A.A. - McCall N. (1977), Coinsurance and the Demand for Physician Services: Four Years Later, Soc. Secur. Bull., vol.40, no.5, pp. 19-27.
67. Scitovsky A.A. - Snyder N.M. (1972), Effect of Coinsurance on the Demand for Physician Services, Soc. Secur. Bull, vol.35, no.6, pp. 3-19.
68. Scott D.M. - Nordin J. - Lally J. (1990), Medication Fees and their Impact on Prescribing Habits for the Near-Poor, J. Pharmacoepidem, vol.1, no.1, pp. 23-33.
69. Selby J.V. - Fireman B.H. - Swain B.E. (1996), Effect of a Copayment on Use of the Emergency Department in a Health Maintenance Organization, New England Journal of Medicine, vol.334, pp. 635-641.
70. Soumerai S.B. - Ross-Degnan D. - Avorn J. - McLaughlin T.J. - Choodnovskiy I. (1991), Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes, New England Journal of Medicine, vol.325, no.15, pp. 1072-1077.
71. Soumerai S.B. - McLaughlin T.J. - Ross-Degnan D. - Casteris C.S. - Bollini P. (1994), Effects of Limiting Medicaid Drug-Reimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients with Schizophrenia, New England Journal of Medicine, vol.331, no.10, pp. 650-655.
72. Soumerai S.B. - Ross-Degnan D. - Fortress E.E. - Walser B.L. (1997), Determinants of Change in Medicaid Pharmaceutical Cost-Sharing: Does Evidence Affect Policy?, Milbank Quarterly, vol.75, no.1, pp. 11-34.
73. Starmans B. - Janssen R. - Schepers M. - Verkooijen M. (1994), The Effect of a Patient Charge and a Prescription Regulation on the Use of Antihypertension Drugs in Limburg, The Netherlands, Health Policy, vol.26, no.3, pp. 191-206.
74. Steinman M.A. - Sands L. - Covinsky K. (2001), Self-Restriction of Medications Due to Cost in Seniors without Prescription Coverage: A National Survey, Journal of General Internal Medicine, vol.16, no.12, pp. 793-799.
75. Stuart B. - Grana J. (1998), Ability to Pay and the Decision to Medicate, Medical Care, vol.36, no.2, pp. 202-211.
76. Stuart B. - Zacker C. (1999), Who Bears the Burden of Medicaid Drug Copayment Policies?, Health Affairs, vol.8, no.2, pp. 201-212.
77. Tamblyn R. (2001), The Impact of Pharmacotherapy Policy: A Case Study, Canadian Journal of Clinical Pharmacology, vol.8, pp. 39A-44A.
78. Tamblyn R. - Laprise R. - Hanley J.A. et al. (2001), Adverse Events Associated with Prescription Drug Cost-Sharing among Poor and Elderly Persons, Journal of American Medical Association, vol.285, pp. 421-429.
79. US Congress (1992), Department of Health and Human Services, United States.
80. Van Doorslaer E. - Wagstaff A. - Van der Burg H. - Christiansen T. - Citoni G. (1999), The Redistribute Effect of Health Care Fmance in Twelve OECD Countries, Journal of Health Economics, vol.18, no.3, pp. 291-313.
81. Van Vliet et al. (1999), Effecten van eigen betalingen op ziepketosten in Nederland, Tijdschrift voor Gezondheisdswetenschappen, vol.77, pp. 397-405.
82. Vella F. (1998), Estimating Models with Sample Selection Bias: A Survey, Journal of Human Resources, vol.33, no.1, pp. 127-172.
83. VonKorff, M. - Wagner E.H. - Saunders K. (1992), A Chronic Disease Score from Automated Pharmacy Data, Journal of Clinical Epidemiology, vol.45, no.2, pp. 197-203.
84. Wagstaff A. - Van Doorslaer E. (1992), Equity in the Finance of Health Care: Some International Comparisons, Journal of Health Economics, vol.11, no.4, pp. 361-387. (Pubitemid 23062330)
85. Wagstaff A. et al. (1999), Equity in the Finance of Health Care: Some Further International Comparisons, Journal of Health Economics, vol.18, no.3, pp. 263-290.